Press Release of financial results for the quarter ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Limited reported strong financial results for Q3 FY25-26 (quarter ended 31 December 2025). Standalone revenue from operations grew 13% year-on-year to ₹2,303.20 Lakhs, while profit after tax (PAT) surged 511% YoY to ₹95.07 Lakhs, and basic EPS rose 443% to ₹0.38. For the nine-month period, standalone revenue was up 27% YoY at ₹6,890.61 Lakhs with PAT up 94% at ₹206.29 Lakhs. On a consolidated basis, nine-month revenue rose 12% YoY to ₹6,092.96 Lakhs with PAT up 108% to ₹215.36 Lakhs. The company highlighted cost optimisation, expansion into higher-margin R&D-driven categories, and improved production efficiency as key drivers. It also completed UAE product registration, with the first export consignment expected in Q1 of the next financial year, and noted encouraging response to its new nutraceutical weight wellness range.
Strong profit growth and improving margins suggest a positive earnings story that could support investor sentiment, though the sharp YoY PAT jump partly reflects a low base. Progress on exports and new product categories signals potential future revenue diversification.